Intensive insulin treatment is a standard of care for tight glycemic control in people with diabetes, to prevent or delay long-term complications of diabetes mellitus [1–3] However, insulin therapy may cause life threatening hypoglycemia and thus achieving and maintaining near normoglycemia is largely limited by this risk factor [4], which persists despite advances in treatment technique [2–6]. The gene discussed is INS; the disease is diabetes mellitus.